Author: admin

Food Diagnostics Market Overview, Growth Drivers, Key Segments, Latest Trends, Regional Insight, Recent Developments, and Top Companies

“MarketsandMarkets™”
Food Diagnostics Market by Type (Systems, Test Kits, and Consumables), Testing Type (Safety and Quality), Site (Outsourcing Facility and Inhouse), Food Tested (Meat, Poultry & Seafood, Dairy Products, Processed Food) and Region – Global Forecast to 2028

The food diagnostics market size is valued at USD 16.2 billion in 2023 and is expected to grow to USD 23.5 billion by 2028, with a CAGR of 7.7% during this period. Food diagnostics refers to the set of processes and techniques used to assess and validate food products, ensuring they meet safety, quality, authenticity, and regulatory standards. These procedures include various testing methods and analytical tools applied throughout the food supply chain, from production and processing to distribution and consumption. They play a critical role in maintaining and evaluating key quality attributes such as taste, texture, color, aroma, and overall sensory properties of food products.

Food Diagnostics Market

Global Food Diagnostics Market Drivers:

The surge in food recalls has significantly driven the growth of the food diagnostics industry, fueled by heightened concerns over food safety and public health. Contaminated or unsafe food products can lead to serious consequences, including illnesses, hospitalizations, and even fatalities. This increased focus on food safety has encouraged regulatory authorities and food manufacturers to invest in advanced diagnostic technologies. These solutions provide rapid and accurate detection of contaminants, pathogens, allergens, and adulterants, helping prevent tainted products from reaching consumers. Additionally, the financial and reputational risks associated with recalls have pushed companies to adopt state-of-the-art diagnostic tools, contributing to the expansion of the food diagnostics market.

Food Diagnostics Market Trends

Here are some of the key trends currently shaping the Food Diagnostics Market:

Increased Focus on Food Safety and Quality Control: Rising consumer demand for safe and high-quality food products is driving the adoption of advanced diagnostics technologies to detect contaminants, pathogens, and toxins across the food supply chain.

Growth of Rapid Diagnostic Technologies: Rapid testing solutions, such as PCR-based tests, biosensors, and immunoassays, are gaining traction as they offer faster and more accurate results, reducing the time between sample collection and analysis.

Automation and AI Integration: Automation in food testing labs, coupled with AI and machine learning algorithms, is enhancing the efficiency, speed, and precision of food diagnostics, particularly for large-scale operations.

Rising Need for Allergen Testing: With food allergies becoming more prevalent, the demand for testing products that can detect allergens in processed and packaged foods is increasing, encouraging innovation in this niche.

Growth in Non-Destructive Testing Methods: Non-invasive and non-destructive diagnostic methods, such as spectroscopy and imaging technologies, are becoming more common to ensure food quality without damaging the products.

Stringent Regulatory Frameworks: Governments and regulatory bodies are imposing stricter standards for food safety, which is pushing food manufacturers to adopt more rigorous diagnostics systems to comply with these regulations.

Focus on Sustainable Food Production: As sustainability becomes a priority in the food industry, there is an increased focus on testing methods that are environmentally friendly, using fewer chemicals and generating less waste.

Emergence of Blockchain for Food Traceability: Blockchain technology is being integrated with food diagnostics systems to enhance transparency, traceability, and data integrity in the food supply chain, ensuring that any contamination is easily traceable.

Food Diagnostics Market Opportunities: Increased budget allocation and expenditure on food safety

Governments, regulatory bodies, and key players in the food industry around the world are increasingly recognizing the critical importance of safeguarding the food supply chain. This heightened awareness has spurred a significant rise in investments in food safety initiatives, driving innovation and expansion within the food diagnostics market. The adoption of cutting-edge technologies, such as DNA-based testing and rapid pathogen detection, is accelerating, providing more accurate and efficient food monitoring from production to consumption. Additionally, growing consumer awareness of foodborne diseases and the increasing demand for transparency in the supply chain have amplified the need for comprehensive diagnostic solutions. As a result, the evolving landscape offers substantial opportunities for companies to create advanced diagnostic tools and services, positioning the food diagnostics market for considerable growth and improved food safety.

Asia Pacific Projected to Lead Global Food Diagnostics Market Growth with Highest CAGR

The Asia Pacific region is undergoing notable population growth, urbanization, and a rise in disposable income. Countries such as China and India are experiencing rapid population increases, which has led to higher food consumption. This surge in demand underscores the critical need for effective food safety and quality testing. As more individuals move to urban areas, there is a growing demand for processed and packaged foods. This escalating demand necessitates rigorous quality control and safety measures, thereby propelling the growth of the food diagnostics market.

Additionally, the food supply chain in the Asia Pacific is becoming more intricate due to globalization and the expansion of international trade. This complexity requires thorough testing and monitoring throughout the entire supply chain, from farm to table. Consequently, food diagnostics solutions are increasingly vital for ensuring the safety and quality of food products.

Top Food Diagnostics Companies:

Bio-Rad Laboratories Inc. (US), Thermo Fisher Scientific Inc. (US), Shimadzu Corporation (Japan), Neogen Corporation (US), BioMerieux (France), Agilent Technologies Inc. (US), Merck KGaA (Germany), QIAGEN (Germany), Bruker (US), and Danaher (US) are among the key players in the global food diagnostics market. To increase their company’s revenues and market shares, companies are focusing on launching new products, developing partnerships, and acquiring other companies. The key strategies used by companies in the food diagnostics market include geographical expansion to tap the potential of emerging economies, strategic acquisitions to gain a foothold over the extensive supply chain, and new product launches as a result of extensive research and development (R&D) initiatives.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=225194671

Key Questions Addressed by the Food Diagnostics Market Report:

What is the food diagnostics market?

Why is food diagnostics important?

Which segment by food tested accounted for the largest food diagnostics market share?

What are the major drivers of the food diagnostics market?

What are the challenges faced by the food diagnostics market?

Who are the key players in the food diagnostics market?

What are the emerging trends in the food diagnostics market?

How is the food diagnostics market expected to grow in the coming years?

What is the future outlook for the food diagnostics market?

Which region is projected to account for the largest share of the food diagnostics market?

What is the current size of the global food diagnostics market?

Schedule a call with our Analysts to discuss your business needs: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=225194671

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

 

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/food-diagnostics-systems-225194671.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Food Diagnostics Market Overview, Growth Drivers, Key Segments, Latest Trends, Regional Insight, Recent Developments, and Top Companies

Dental Equipment Market Size Worth USD 10.90 Billion By 2031 | CAGR 6.10% : Skyquest Technology

“Dental Equipment Market”
Global Dental Equipment Market size was valued at USD 10.90 billion by 2031, growing at a CAGR of 6.10% during the forecast period (2024-2031).

Global Dental Equipment Market size was valued at USD 6.4 billion in 2022 and is poised to grow from USD 6.79 billion in 2023 to USD 10.90 billion by 2031, growing at a CAGR of 6.10% during the forecast period (2024-2031).

Growing emphasis on oral care and rising incidence of dental diseases around the world is projected to boost sales of dental equipment across the study period. Increasing the number of people opting for cosmetic dentistry procedures will also create new business scope for dental equipment providers in the long run. Use of advanced technologies to improve the efficacy of dental equipment will also create new opportunities for market players in the future, 

Dental equipment companies should primarily focus on improving accessibility and affordability for their offerings in underdeveloped and developing countries. Designing dental equipment for specific dental surgeries and procedures will also offer some highly rewarding opportunities in the future. 

 

Get a Free Sample Research Report:

https://www.skyquestt.com/sample-request/dental-equipment-market

 

Dental Equipment Market Segmental Analysis

Global Dental Equipment Market is segmented by Product, End User, and region. 

Based on Product, the market is segmented into Therapeutic Dental Equipment, and Dignostic Dental Equipment. 

Based on End User, the market is segmented into Dental Hospitals and Clinics, Dental Academic & Research Institutes, and Other End Users. 

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

 

New Dental Equipment Launches – Key Revenue Generator for Dental equipment Providers

Dental equipment companies should focus on continually launching new products to stay competitive in this market. Integrating advanced technologies to improve workflow and functionality will also create new opportunities for dental equipment manufacturers. Collaborating will also be a key strategy for market players looking to fast-track their research and development processes. Entering emerging markets is also expected to provide some highly lucrative business opportunities for dental equipment companies in the long run. Dental equipment providers can also work closely with governments and regulatory bodies to make their products more compliant. Venturing into the refurbished dental equipment space will also be a major trend for all dental equipment companies across the study period and beyond. 

  • In July 2024, Flight Dental Systems announced the launch of a new sterilizer for dental establishments. The Flight Clave45+ Steam Sterilizer from the Canadian dental equipment provider is available with a 45-litre chamber capacity and is designed to meet all sterilization standards required.
  • GulfDrug in July 2024, announced the launch of a new dental care unit. intended to revolutionize dental care through its new launch and expanded its business scope in the dental field.  
  • In June 2023, A-dec, a renowned supplier of dental equipment based in the United States announced the launch of new digitally connected dental chairs. The company also launched the A-dec 500 Pro and A-dec 300 Pro delivery platforms to stay competitive in this market.
  • A new redesigned dental delivery system was launched by Midmark Corp. The new offering launched in January 2024 was intended to streamline the veterinary workflow through its compact design and next-generation features.  

 

Ask for Customization:

https://www.skyquestt.com/speak-with-analyst/dental-equipment-market

 

This report covers the following players:

  • Planmeca Group (Finland) 
  • Envista Holdings Corporation (US) 
  • Dentsply Sirona Inc (US) 
  • A-dec (US) 
  • J. Morita Group (Japan) 
  • Align Technology (US) 
  • Mitsui Chemicals, Inc. (Japan) 
  • GC Corporation (Japan) 
  • Midmark Corporation (US) 
  • Ivoclar Vivadent AG (Liechtenstein) 
  • Institut Straumann AG (Switzerland) 
  • Biolase (US) 
  • 3M (US) 
  • BEGO (Germany) 
  • Yoshida Dental (Japan) 
  • Nakanishi (Japan) 
  • DentalEZ (US) 
  • Ultradent Products, Inc. (US) 
  • Brasseler USA (US) 
  • PreXion (US) 
  • AMD Lasers (US) 
  • Aseptico (US) 
  • Bien-Air Dental (Switzerland) 
  • Bisco, Inc. (US) 
  • Millenium Dental Technologies (US)

 

View report summary and Table of Contents (TOC):

https://www.skyquestt.com/report/dental-equipment-market

 

This report covers the following segments:

  1. A. Product
  2. Therapeutic Dental Equipment [Dental Operatory & Treatment Center Equipment (Dental Units {Instrument Delivery Systems, Dental Chairs}, Dental Handpieces, Dental Light-curing Equipment, Electrosurgical Systems, Other Dental Operatory & Treatment Center Equipment), Dental Laboratory Equipment (CAD/CAM Systems, Milling Equipment, 3d Printing Equipment, Casting Machines, Ceramic Furnaces, Other Dental Laboratory Equipment), Dental Lasers (Soft-tissue Lasers {Diode Lasers, Carbon-dioxide Lasers, ND-YAG Lasers}, All-tissue Lasers {ER:YAG Lasers, ER, CR:YSGG Lasers})]
  3. Diagnostic Dental Equipment [Extraoral Imaging Systems (Panoramic Systems, 3D CBCT Systems, Panoramic & Cephalometric Systems), Intraoral Imaging Systems, Intraoral X-Ray Systems, Dental Imaging Software]
  4. B.  End User
    1. Dental Hospitals and Clinics
    2. Dental Academic & Research Institutes
    3. Other End Users [DSO, Dental Laboratories]

 

Visit Our Website: https://www.skyquestt.com/

 

Market Remains Opportune but Choosing Right Strategy Will Determine Success 

New product launches will remain the preferred and mainstay strategy for almost all dental equipment companies. Investing in the development of new dental equipment equipped with advanced digital technologies will be a major trend for all market players going forward. The global dental equipment market is highly opportune but choosing the right strategy is crucial for success in the future.

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/dental-equipment-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Dental Equipment Market Size Worth USD 10.90 Billion By 2031 | CAGR 6.10% : Skyquest Technology

Serverless Computing Market Size, Share, Latest Trends, Growth Factors, Industry Analysis, Advance Technology And Forecast -2029

“AWS (US), Microsoft (US), IBM (US), Google (US), Oracle (US), Alibaba Cloud (China), Tencent Cloud (China), Twilio (US), Cloudflare (US), MongoDB (US), Netlify (US), Fastly (US), Akamai (US), Digitalocean (US), Datadog (US), Vercel (US), Spot by NetApp (US), Elastic (US), VMware (US), Backendless (US), Faundb (US), Scaleway (US), 8Base (US), Supabase (US), Appwrite (US).”
Serverless Computing Market by Service Model (Function as a Service, Backend as a Service), Compute (Functions, Containers), Database (Relational, Non-relational), Storage, Application Integration, Monitoring & Security – Global Forecast to 2029.

The serverless computing market is projected to experience a Compound Annual Growth Rate (CAGR) of 15.3% during the forecast period, increasing from USD 21.9 billion in 2024 to USD 44.7 billion by 2029. The global serverless computing sector is flourishing as it enhances project transparency, optimizes resource allocation, and supports more informed decision-making. By leveraging a unified platform, companies can efficiently manage and control multiple international projects, ensuring consistent performance and streamlined operations across different regions. This approach allows businesses to scale effectively, adapt to market shifts, and maintain a competitive edge while managing complex project portfolios more efficiently.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=217021547  

“As per service model, the backend-as-a-service (BaaS) will grow at the highest CAGR during the forecast period.”

Backend-as-a-service (BaaS) is essential in the serverless computing sector, making backend tasks easier through different managed services. BaaS provides fundamental functionalities like file storage and management, user authentication and management, database management, and push notification delivery. By outsourcing these backend duties to external firms, developers can focus on front-end development and application logic, leading to faster development and decreased operating expenses. This method facilitates smoothly incorporating different backend services, allowing for scalable and effective app development. With organizations looking to improve their development processes, BaaS offers a way to increase flexibility and streamline backend operations in serverless computing.

“As per vertical, IT & Telecom holds the largest share during the forecast period.”

The IT & telecom industry leads the way in the serverless computing market, utilizing its features to promote innovation and productivity. Serverless computing helps telecom companies improve operations by reducing the need to manage infrastructure and scaling as needed to accommodate changing demands. This vertical sees major advantages from serverless architectures in network function virtualization (NFV), real-time data processing, and content delivery networks (CDNs). Implementing serverless models enables IT & telecom providers to improve service delivery, decrease latency, and optimize resource usage. By incorporating serverless computing into their operations, these businesses can quickly implement new capabilities, uphold high availability, and meet the rising need for digital services, all while cutting operational costs and complexity to stay ahead in a fast-changing tech environment.

“As per region, Asia Pacific will grow at the highest CAGR during the forecast period.”

The rapid growth of the serverless computing market in the Asia-Pacific region is due to the quick uptake of cloud technologies, digital transformation projects, and strong tech communities in nations such as China, India, and Japan. This area, with its different economies and levels of technology, is starting to realize more and more the advantages of serverless computing for scalability, cost saving, and speeding up innovation. Effective and economical cloud options are vital in industries like e-commerce, finance, telecommunications, and manufacturing, where serverless designs are improving functions and service provision. However, in addition to the opportunity that challenges such as adhering regulations or where data needs to (or does not need to) reside may provide, there are also level differences of cloud infrastructure readiness across the region. Companies which provide clouds on a massive scale, AWS, Microsoft Azure and Alibaba Cloud are spending up large in Asia at the moment building data centers right across every country making sure they meet all of these key regulations. Furthermore, governments in the area are pushing for digitization and positive regulatory environments driving interest towards cloud technology as well. Continued digital infrastructure investments and growing adoption of cloud-native technologies in enterprises in Asia-Pacific are expected to drive strong growth in the market for serverless computing, particularly among companies in the digital economy sector.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=217021547  

Unique Features in the Serverless Computing Market

One of the most distinctive aspects of serverless computing is its ability to scale automatically, without the need for businesses to manage the underlying infrastructure. Serverless platforms adjust resources dynamically based on demand, ensuring applications can handle varying workloads without overprovisioning or underutilizing resources. This eliminates the complexity and costs associated with manually scaling servers, providing greater flexibility for businesses of all sizes.

Serverless computing operates on a consumption-based pricing model, which means businesses only pay for the compute resources they actually use. This is a unique departure from traditional cloud models where companies must reserve and pay for server capacity, whether or not it’s fully utilized. The pay-as-you-go model results in significant cost savings, especially for applications with unpredictable or sporadic traffic.

Another defining feature of serverless computing is its event-driven architecture. Functions or tasks are triggered by specific events, such as database updates, user requests, or file uploads. This allows applications to run seamlessly without the need for constant server management, improving efficiency and response times. It’s particularly beneficial for applications that require real-time processing and integration with various services.

Serverless platforms empower developers to focus on writing code without worrying about the underlying infrastructure. This results in faster development cycles and quicker deployment of applications. Additionally, serverless environments support modular programming, allowing developers to write smaller, isolated functions that are easier to maintain and deploy independently, leading to improved productivity and faster time-to-market.

Serverless computing platforms inherently offer high availability and fault tolerance. Providers ensure that applications are automatically replicated across multiple data centers, reducing the likelihood of downtime and enhancing reliability. This means businesses don’t have to invest additional resources in designing and managing redundant infrastructure to achieve resilience.

Major Highlights of the Serverless Computing Market

One of the key highlights of serverless computing is its cost-efficiency, thanks to the pay-as-you-go model. Businesses only pay for the resources they actually use, leading to substantial cost savings. This, combined with the automatic scaling feature, ensures optimal resource utilization, preventing the overprovisioning that often occurs with traditional cloud computing models. Companies can therefore minimize operational costs while maximizing the efficiency of their applications.

Serverless computing allows developers to focus on writing and deploying code without worrying about infrastructure management. This results in shorter development cycles and faster time-to-market for applications. The ability to deploy individual functions rather than entire applications enables modular development, making updates, fixes, and new features easier to implement.

Serverless computing is based on an event-driven architecture, where functions are executed in response to specific events, such as HTTP requests, file uploads, or database changes. This model is ideal for applications requiring real-time processing and enables highly responsive systems. It also allows businesses to build more flexible, scalable applications that adapt to varying workloads without manual intervention.

Serverless computing offers inherent scalability by automatically adjusting resources based on the current demand. This eliminates the need for manual provisioning of servers, making it easier for businesses to handle spikes in traffic or varying workloads. Applications can scale seamlessly without the risk of downtime or performance issues, making serverless computing particularly advantageous for enterprises with fluctuating usage patterns.

Serverless platforms provide built-in high availability and fault tolerance. Providers ensure that applications run across multiple data centers, significantly reducing the risk of downtime or service interruptions. Businesses benefit from greater resilience and reliability without having to manage redundant infrastructure or design complex failover systems.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=217021547  

Top Companies in the Serverless Computing Market

Major vendors in this market are in North America and Europe. AWS, Microsoft, Google, IBM, and Oracle are among the leading Serverless Computing market players. These firms have implemented a variety of growth tactics to increase their market position. These can include product launches, contracts, collaborations, mergers & acquisitions, and geographical expansion by developing new products.

Amazon Web Services (AWS)

Amazon Web Services, known as AWS. In addition to the traditional services like compute, storage, and databases, it provides more advanced resources, including options for Artificial Intelligence (AI), Machine Learning suites with AWS, or Internet of Things solutions using their lambda-services. AWS serves enterprises at all stages with hyper-scalable, elastic solutions that run across a genuinely worldwide data center-based availability zone to reduce latency and increase reliability. Competitive product pricing, an expanded group of services offered, and a less disruptive ability to incorporate new features make AWS stand out in the cloud market due to its top-notch security, compliance with all regulations, and comprehensive customer support. On the list of serverless computing brands is AWS, which has a lauded selection of tools developers can use to run apps without managing servers. AWS Lambda is a serverless event-driven compute service; AWS Fargate lets you run containers without managing servers or clusters (like ECS by default); Amazon API Gateway enables creation, publishing, and securing of Restful APIs with ease; Step Functions from AWS are used for indeed executing workflows in the cloud ecosystem & DynamoDB which can be called as an enterprise-grade NoSQL database available to us. These tools help companies concentrate on building applications, scale quickly, and reduce costs by managing the underlying infrastructure to accelerate product launches.

Microsoft

Microsoft Corporation was founded in 1975 and is a global software, services, devices & solutions provider with products that span the Desktop to Cloud: Windows operating system (OS), Office suite of productivity apps SharePoint servers or CRM Dynamics, Xbox gaming platform; Azure for hosting web-based workloads alongside LinkedIn an online network connecting professionals. Microsoft is a global technology leader that creates productivity and communication services for consumers, SMBs, and enterprise dashboards in sectors spanning AI to mixed reality to cybersecurity innovations. Azure Functions -Event-driven serverless computing and Azure Logic Apps for automated workflow; event-based notification solutions are core in Microsoft’s approach to flat-out solving workloads on top of their dynamic virtual machines. Developers can develop and launch apps with no infrastructure to manage, providing flexibility, scalability, and connection to other Azure services. Their cloud ecosystem, ease of use, and enterprise-level support by Microsoft make Azure an attractive option for businesses looking to deploy their serverless computing with many applications.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/serverless-computing-market-217021547.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Serverless Computing Market Size, Share, Latest Trends, Growth Factors, Industry Analysis, Advance Technology And Forecast -2029

Glioblastoma Pipeline Insights, Treatment Drugs, Clinical Trials, and Companies 2024

DelveInsight’s, “Glioblastoma Pipeline Insight 2024” report provides comprehensive insights about 195+ companies and 210+ pipeline drugs in Glioblastoma pipeline landscape. It covers the Glioblastoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioblastoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Explore our comprehensive Glioblastoma Pipeline Report to stay informed about the latest advancements. Download copy now @ Glioblastoma Pipeline Outlook

 

Key Takeaways from the Glioblastoma Pipeline Report

  • In September 2024:- Novartis Pharmaceuticals- An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib). A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
  • In September 2024:- GT Medical Technologies Inc.- A Randomized Controlled Trial of Surgical Resection With GammaTile Therapy and Adjuvant Systemic Therapy Compared to Surgical Resection and Adjuvant Systemic Therapy at First Recurrence in Glioblastoma.
  • August 2024:- Acerta Pharma BV- A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM). A Phase 1b/2, multicenter, open-label study was designed to evaluate the efficacy and safety of acalabrutinib in subjects with recurrent glioblastoma multiforme (GBM) who had progressed after one or two prior systemic treatment regimens.
  • August 2024:- ImmunityBio Inc.- Open-label Phase 2 Study of N-803 and PD-L1 t-haNK Combined With Bevacizumab in Subjects With Recurrent or Progressive Glioblastoma. This is a phase 2 open-label study to evaluate the safety and efficacy of N-803 and PD-L1 t-haNK when combined with Bevacizumab in subjects with recurrent or progressive GBM.
  • DelveInsight’s Glioblastoma pipeline report depicts a robust space with 195+ active players working to develop 210+ pipeline therapies for Glioblastoma treatment.
  • The leading Glioblastoma Companies such as Denovo BioPharma, Pfizer, Vigeo Therapeutics, Celldex Therapeutics, Debiopharm, Prelude Therapeutics, AiVita Biomedical, Ascletis Pharma, Kintara Therapeutics, Bayer AG, Kazia Therapeutics, GlaxoSmithKline, Candel Therapeutics, Symphogen A/S, Sanofi, Oblato, Jiangsu Hengrui Medicine, BPGbio, Inc., Alaunos Therapeutics, Eli Lilly and Company, Actuate Therapeutics, Oncotelic Therapeutics, The Menarini Group, SonALAsense, Novartis, Allarity Therapeutics, PharmAbcine, I-Mab Biopharma Co. Ltd., Aadi Bioscience, Inc., Matrix Biomed, Photonamic GmbH & Co. KG, Lixte, Black Diamond Therapeutics, Tmunity Therapeutics, SOM Biotech, Moleculin, Xynomic Pharmaceuticals, OncoSynergy, and others.
  • Promising Glioblastoma Therapies such as Axumin, Intravenous Solution, PolyMVA, MDNA55, Erlotinib HCl (OSI-774), BPM31510, Temozolomide (TMZ), and others.

 

Dive into our Glioblastoma Pipeline Report to uncover promising therapies and breakthroughs. Gain insights that could shape the future of oncology @ Glioblastoma Treatment Therapies

 

Glioblastoma Emerging Drugs Profile

  • Enzastaurin: Denovo BioPharma

DB102 (enzastaurin) is an orally available investigational first-in-class small molecule, serine/threonine kinase inhibitor of the PKC beta, PI3K, and AKT pathways that has been studied in more than 3,000 patients across a range of solid and hematological tumor types. DB102 was originally developed by Eli Lilly and for which Denovo has acquired worldwide rights. DB102 received Orphan Drug Designation in DLBCL and glioblastoma multiforme (GBM) from the FDA and EMA and Fast Track Designation from the FDA. DB102 is the world’s first oral small-molecule kinase inhibitor targeting PKC. A retrospective analysis found that it has significant curative effects in high-risk DLBCL patients who are DGM1 positive. The company has initiated a biomarker guided Phase III clinical study evaluating the DB102 (enzastaurin) in combination with temozolomide and radiation as first line therapy to treat newly-diagnosed glioblastoma multiforme (GBM).

  • Tofacitinib: Pfizer

Tofacitinib (Xeljanz, Jaquinus) is an immunosuppressant. It is a first-generation, orally bioavailable pan-Jak inhibitor. Tofacitinib was mainly developed for use as an immunosuppressant for organ transplantation and possibly for the treatment of autoimmune diseases. Tofacitinib suppresses the Jak family members at IC50s as follows: Jak1, Jak2, and Jak3, in a cell-free kinase assay. In addition, Tofacitinib effectively suppresses common γ-chain cytokines involving IL-2, IL-4, IL-15 and IL-21. Furthermore, the most common side effects include headaches, upper respiratory infections, diarrhea, and nasopharyngeal inflammation, elevation in low-density lipoprotein and cholesterol levels and reduction in neutrophil numbers. Serious infections including pneumonia, cellulitis and urinary tract infections have been described in patients treated with Tofacitinib. Currently, the drug is in the Phase III stage of its development for the treatment of glioblastoma multiforme.

  • VT1021: Vigeo Therapeutics

Vigeo’s lead asset, VT1021, is a first-in-class dual modulating compound that blocks the CD47 immune checkpoint and activates CD36, which induces apoptosis and increases the M1:M2 macrophage ratio. VT1021 achieves this through stimulation of thrombospondin-1 (Tsp-1). The goal of these dual-modulating effects is conversion of immuno-suppressive, or “cold,” tumors that don’t respond to immuno-oncology agents, to immuno-stimulated, or “hot,” tumors that are potentially more receptive to immuno-oncology agents. Vigeo is developing VT1021 as a therapeutic agent across a range of cancers, with a current focus on solid tumors. Vigeo Therapeutics is advancing VT1021 into a Phase II/III registrational study through the company’s collaboration with the Global Coalition for Adaptive Research (GCAR).

  • Varlilumab: Celldex Therapeutics

Varlilumab is a fully human monoclonal antibody that targets CD27, a critical molecule in the activation pathway of lymphocytes. CD27 can be effectively manipulated with activating antibodies to induce potent anti-tumor responses and may result in fewer toxicities due to its restricted expression and regulation.

Varlilumab is a potent anti-CD27 agonist that induces activation and proliferation of human T cells when combined with T cell receptor stimulation. Varlilumab has completed a Phase I dose-escalation study, demonstrating potent immunologic activity consistent with its mechanism of action and anti-tumor activity in patients with advanced, refractory disease. No maximum tolerated dose was reached and minimal toxicities were observed. Celldex initiated a broad development program for varlilumab to explore its role as an immune activator in combination with a number of complementary investigational and approved oncology drugs. Currently, the drug is in the Phase II stage of its development for the treatment of glioblastoma multiforme.

  • Debio 0123: Debiopharm

Debio 0123 is a Wee1 kinase inhibitor. The compound is being developed based on the deepened understanding of the DNA damage response (DDR) of cancer cells. Inhibition of WEE1 prevents cells to arrest or repair DNA damages and force them to prematurely continue through the cell cycle, therefore accumulating unrepaired DNA damages ultimately leading to cell death. The compound is being developed in light of the need to improve cancer patients’ treatment response and to overcome treatment resistance to current therapies. Pre-clinical models have shown anti-tumor activity both as a single agent and in combination with carboplatin. The advancement of Debio 0123 into clinical studies will assess the therapeutic results for cancer patients in various tumor types. Currently, the drug is in the Phase I/II stage of its development for the treatment of Glioblastoma.

  • PRT3645: Prelude Therapeutics

PRT3645 is Prelude’s next generation CDK4/6 inhibitor with high tissue distribution and brain penetration. In preclinical studies, PRT3645 treatment resulted in concentration-dependent inhibition of cell proliferation in both glioblastoma (GBM) cell lines and in ER+/HER2- and HER2+ breast cancer lines. In vivo, orally administered PRT3645 was well tolerated and highly efficacious in a dose-dependent manner in orthotopic human breast cancer brain metastasis and GBM models. Currently, the drug is in the Phase I stage of its development for the treatment of Glioblastoma.

 

Download the Glioblastoma Pipeline Report to discover partnership opportunities and collaborate in driving impactful solutions forward @ Glioblastoma Clinical Trials Assessment

 

Glioblastoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

  • Oral
  • Intravenous
  • Subcutaneous
  • Parenteral
  • Topical

 

Glioblastoma Products have been categorized under various Molecule types such as

  • Recombinant fusion proteins
  • Small molecule
  • Monoclonal antibody
  • Peptide
  • Polymer
  • Gene therapy 

 

Dive into our detailed Glioblastoma Pipeline Report to discover groundbreaking advancements shaping the future of cancer treatment @ Glioblastoma Products, Companies, and Unmet Needs

 

Scope of the Glioblastoma Pipeline Report

  • Coverage- Global
  • Glioblastoma Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Glioblastoma Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
  • Glioblastoma Companies- Denovo BioPharma, Pfizer, Vigeo Therapeutics, Celldex Therapeutics, Debiopharm, Prelude Therapeutics, AiVita Biomedical, Ascletis Pharma, Kintara Therapeutics, Bayer AG, Kazia Therapeutics, GlaxoSmithKline, Candel Therapeutics, Symphogen A/S, Sanofi, Oblato, Jiangsu Hengrui Medicine, BPGbio, Inc., Alaunos Therapeutics, Eli Lilly and Company, Actuate Therapeutics, Oncotelic Therapeutics, The Menarini Group, SonALAsense, Novartis, Allarity Therapeutics, PharmAbcine, I-Mab Biopharma Co. Ltd., Aadi Bioscience, Inc., Matrix Biomed, Photonamic GmbH & Co. KG, Lixte, Black Diamond Therapeutics, Tmunity Therapeutics, SOM Biotech, Moleculin, Xynomic Pharmaceuticals, OncoSynergy, and others.
  • Glioblastoma Therapies- Axumin, Intravenous Solution, PolyMVA, MDNA55, Erlotinib HCl (OSI-774), BPM31510, Temozolomide (TMZ), and others.

 

Gain valuable insights into emerging therapies and innovations with our Glioblastoma Pipeline Report @ Glioblastoma Market Drivers and Barriers, Future Perspectives and Analyst Views

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Glioblastoma: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Glioblastoma– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Enzastaurin: Denovo BioPharma
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. Varlilumab: Celldex Therapeutics
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. PRT3645: Prelude Therapeutics
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. ELC-401: Elicera Therapeutics
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Glioblastoma Key Companies
  21. Glioblastoma Key Products
  22. Glioblastoma- Unmet Needs
  23. Glioblastoma- Market Drivers and Barriers
  24. Glioblastoma- Future Perspectives and Conclusion
  25. Glioblastoma Analyst Views
  26. Glioblastoma Key Companies
  27. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Glioblastoma Pipeline Insights, Treatment Drugs, Clinical Trials, and Companies 2024

Multi-Billion Opportunities in the Edtech Market: $738.60 Billion Revenue by 2029, A 2X Growth in the Next 6 Years – Arizton

“EdTech Market Research Report by Arizton”

 

According to Arizton’s latest research report, the edtech market is growing at a CAGR of 14.13% during 2023-2029.

        

Looking for More Information? Click: https://www.arizton.com/market-reports/edtech-market

 

Report Scope:        

Market Size (2029): USD 738.60 Billion

Market Size (2023): USD 334.29 Billion

CAGR (2023-2029): 14.13%   

Historic Year: 2020-2023    

Base Year: 2023     

Forecast Year: 2024-2029   

Market Segmentation: Edtech Business Models, Type, Sector, End-user, and Geography

Geographic Analysis: North America, Europe, APAC, Latin America, and Middle East & Africa       

 

Book the Free Sample Now: https://www.arizton.com/market-reports/edtech-market

 

The Growing Landscape of EdTech: Key Players and Market Dynamics

The learning requirements of corporates, schools, universities, individual learners, and professionals vary significantly based on their expectations and capabilities. Recent technological advances have driven remarkable changes in the edtech market. Both mature markets like the US and Canada and emerging markets such as China and India have experienced sharp increases in edtech activity, fueled by favorable venture capital investments and ongoing technological innovations. Edtech startups have effectively bridged the gap between traditional and innovative education methodologies, attracting many investors eager to support digital solutions in education.

Most edtech startups are based in the US, a country known for its focus on innovation, which has significantly contributed to the sector’s expansion. As of 2023, the US leads in the number of unicorn enterprises, with funding for US-based edtech companies doubling from 2016 to a notable $2.2 billion in 2022. The pandemic accelerated this growth, necessitating a swift transition to online learning. However, investment capital distribution in the US remains uneven, with major fundraising rounds concentrated in innovation hubs like the Bay Area, New York, and Chicago.

In Europe, the edtech market is thriving, with substantial growth in venture capital funding across the region. Between 2014 and 2019, there was a nine-fold increase in transaction sizes, and this trend continues as investments in edtech become more robust. Countries like the UK, France, and Germany are at the forefront of this transformation, developing innovative solutions such as VR-powered simulations, tutoring apps, and educational marketplaces. Despite this progress, Europe still lags behind the US and certain Asian countries in developing billion-dollar edtech enterprises. However, the region remains fertile ground for emerging companies with a market capitalization of $100 million to $250 million, showcasing exceptional growth potential.

 

Technology’s Impact on the K-12 Education Sector: Growth and Opportunities

The emergence of technology has significantly addressed the unmet needs of students by facilitating virtual interactions with peers and mentors. The widespread adoption of technology in the K-12 sector is primarily driven by increased internet access and higher disposable incomes among families. Online tutoring and e-learning services are now more accessible via smartphones, making them appealing to the growing youth population. Parents are increasingly investing in these supplementary educational services, which enhance their children’s understanding of key concepts. The K-12 segment’s business model typically features smaller average transaction values, contributing to higher consumer adoption during the forecast period.

Despite potential disruptions from technological advancements, demand for K-12 education is expected to be strongly supported by government policies. The data-rich educational ecosystem will enable effective data capture related to learning activities, while integrated technology is anticipated to bring significant benefits to schools and improve user outcomes. Overall, the K-12 segment is projected to achieve an absolute growth of 125.26% during the forecast period, driven by the increasing youth population and rising disposable incomes.

 

Recent Mergers & Acquisitions in Education and Edtech Sectors, 2024

  • In July, EdPower, an LMS provider in the US, was acquired by Prometric, a US-based testing and assessment provider.  The terms were not disclosed.
  • Genius Teacher, an Indian edtech that provides content for primary school teachers, was acquired by Schoolnet, a US K-12 management system.
  • In June, the College of Court Reporting, an Indiana-based, nationally accredited, degree-granting court reporting college, was acquired by a strategic buyer that owns and operates several other vocational colleges.  Jackim Woods represented the seller and arranged the transaction.

 

APAC: An Ideal Region for Edtech Market Opportunities

The Asia-Pacific (APAC) region, home to nearly 60% of the world’s population, is becoming a significant contributor to the global edtech market. Factors such as rising disposable incomes and rapid urbanization are enhancing access to online learning through budget smartphones. While countries like China, South Korea, and India lead the charge, challenges remain in gaining acceptance for digital learning, especially for paid content.

Progressive government policies and an increasing demand for skill development, particularly in English proficiency, are driving investments and infrastructure improvements. As the region witnesses a surge in technology adoption, including AI and AR, the APAC edtech market is projected to grow by an impressive $216.24 billion, fueled by significant funding from investors, particularly in China. This landscape presents both opportunities and hurdles for edtech vendors aiming to scale their offerings amid evolving consumer preferences.

 

Key Company Profiles

  • 2U Inc
  • Anthology Inc.
  • BoxLight
  • Byju’s
  • Udemy
  • Coursera
  • Chegg
  • Duolingo
  • Unacademy
  • Pearson PLC
  • UpGrad
  • VIPKid
  • Fujitsu
  • Promethean World
  • Ellucian
  • Red Shelf
  • Xello
  • Scoir
  • Kahoot
  • BenchPrep
  • Coassemble
  • Codecademy
  • CrossKnowledge
  • FutureLearn
  • GoSkills
  • iHASCO
  • ITPro
  • Khan Academy
  • MasterClass
  • OpenSesame
  • Rosetta Stone
  • Teachlr
  • DataCamp
  • BrainStation
  • Estácio
  • Learnetic
  • Absorb Software
  • Noggin Guru
  • Bridge
  • Degreed
  • Easygenerator
  • EduMe
  • Epignosis
  • ExpertusONE
  • G-Cube
  • Gnowbe
  • iQualify
  • iSpring
  • Kallidus
  • LearnUpon
  • Mindtickle
  • Moodle
  • NovoEd
  • Neovation Learning Solutions
  • Schoox
  • SkyPrep
  • SmartUp
  • Epignosis
  • Teachable
  • THINKIFIC
  • Thought Industries
  • Cisco
  • Instructure
  • GP Strategies
  • Thomson Reuters
  • Docebo
  • McGraw Hill
  • Desire2Learn
  • Edmodo
  • Cengage
  • Macmillan Education
  • Cornerstone
  • Educomp
  • Cogna Educacao
  • Telefonica
  • edX
  • SAP Litmos
  • Open Education
  • Veduca
  • LinkedIn (Microsoft)
  • Simplilearn
  • Think & Learn (BYJU’S)
  • LeQuest
  • FutureLearn
  • L2P (Learn2Play)
  • Bright Little Labs
  • Aula Education
  • WhiteHat Security
  • Blinkist
  • Age of Learning
  • Elearn Australia
  • 360Learning
  • Skillshare
  • Udacity
  • Pluralsight
  • Alison
  • Babbel
  • Treehouse
  • Tracxn Technologies
  • IGNOU
  • BenchPrep
  • Coassemble
  • Codecademy
  • FutureLearn
  • GoSkills
  • Cengage Learning India
  • New Oriental Education & Technology Group Inc.

 

Market Segmentation

 

Edtech Business Models

  • Freemium Model
  • Ad-Based Revenue Model
  • Free Trial & Subscription-Based Model
  • Marketplace Model
  • Institutional Sales Model
  • Recruiting Model
  • Segmentation by Type
  • Hardware
  • Software
  • Technology-Enabled Services

 

Sector

  • K-12
  • Higher Education
  • Competitive Exams
  • Certifications

 

End-user

  • Individual Learners
  • Institutes
  • Enterprises

 

Geography

 

APAC

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Indonesia

 

North America

  • The US
  • Canada

 

Europe

  • The UK
  • France
  • Germany
  • Spain
  • Italy
  • Netherlands

 

Latin America

  • Brazil
  • Mexico
  • Argentina

 

Middle East & Africa

  • The GCC
  • South Africa
  • Nigeria
  • Kenya

 

The Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to thoroughly understand the edtech market. Request for Free Sample to get a glance at the report now: https://www.arizton.com/market-reports/edtech-market

      

What Key Findings Will Our Research Analysis Reveal?      

How big is the EdTech market?

What is the growth rate of the global EdTech market?

Which region dominates the global EdTech market share?

What are the significant trends in the EdTech market?

Who are the key players in the global EdTech market?

      

Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4408

      

Other Related Reports that Might be of Your Business Requirement      

U.S. Continuing Legal Education (Cle) Market – Industry Outlook & Forecast 2024-2029: The U.S. continuing legal education (CLE) market was valued at USD 4.85 billion in 2023 and is expected to reach USD 7.98 billion by 2029, growing at a CAGR of 8.65%. Explore! https://www.arizton.com/market-reports/continuing-legal-education-market

E-Learning Market – Global Outlook & Forecast 2024-2029: The global e-learning market was valued at USD 250 billion in 2023 and is expected to reach USD 490.20 billion by 2029, growing at a CAGR of 11.88% during the forecast period. Learn more: https://www.arizton.com/market-reports/e-learning-market-size-2025

 

Why Arizton?                                                 

100% Customer Satisfaction                                                 

24×7 availability – we are always there when you need us                                                 

200+ Fortune 500 Companies trust Arizton’s report                                                 

80% of our reports are exclusive and first in the industry                                                 

100% more data and analysis                                                 

1500+ reports published till date                               

                    

Post-Purchase Benefit                                             

  • 1hr of free analyst discussion                                             
  • 10% off on customization                          

                   

About Us:                                                                                      

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                                    

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                                     

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                                           

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040/+1 302 469 0707    
Country: United States
Website: https://www.arizton.com/market-reports/edtech-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Multi-Billion Opportunities in the Edtech Market: $738.60 Billion Revenue by 2029, A 2X Growth in the Next 6 Years – Arizton

Water Bus Market worth $1.64 Billion by 2030, at a CAGR of 5.1%

“Water Bus Market”
The global Water Bus Market Size in terms of revenue is estimated to be worth $1.22 billion in 2024 and is poised to reach $1.64 billion by 2030, growing at a CAGR of 5.1% during the forecast period.

The report “Water Bus Market by Propulsion (Fully Electric, Fuel-Powered, Hybrid Electric), Capacity (” The Water Bus Market is estimated to be USD 1.22 billion in 2024 and is projected to reach USD 1.64 billion by 2030 at a CAGR of 5.1 % from 2024 to 2030.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=264760668

Water Bus market is facing growth, driven by increasing urbanization, the rising demand for sustainable and efficient public transportation solutions, and advancements in maritime technologies. The key factors that contributes to the growth includes the adoption of eco-friendly propulsion systems, such as hybrid and fully electric engines. The market is expected to witness substantial investments and strategic partnerships aimed at enhancing operational efficiency. Water bus manufacturers are focusing on developing fuel-efficient and electric water buses which will cater to the customers preferences. Growth in the urban mobility strategies is leading to a higher demand for sustainable travel options. These are among some of the factors that are providing growth for the Water Bus Market.

Browse 199 market data Tables and 51 Figures spread throug 203 Pages and in-depth TOC on “Water Bus Market”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/water-bus-market-264760668.html

Water Bus Market

Based on propulsion, the fuel powered water bus segment is projected to have the highest market share in the forecast period.

Based on propulsion, the fuel powered segment is projected to grow at highest market share during the forecast period, from 2024 to 2030. Because of the well-established infrastructure and extensive usage, the fuel-powered segment of the water bus market is expected to hold the largest market share. The proven dependability and performance of fuel-powered water buses which are usually powered by diesel or other conventional fuels make them appealing to operators searching for dependable, high-capacity transportation. Despite the growing interest in sustainable alternatives due to the higher initial cost and infrastructure associated with electric or hybrid options the market for fuel powered waterbus remains highest in the forecast period.

Based on capacity, the 51-75 passenger segment is expected to grow at the highest CAGR in the Water Bus market during the forecast period.

Based on capacity, the 50-75 passenger segment is expected to grow at the highest CAGR in the Water Bus market from 2024 to 2030. Based on capacity, the 50-75 passenger water bus segment is estimated to hold the highest market share due to its optimal balance between capacity and maneuverability. This size is perfect for city settings, where it can maneuver through small spaces or crowded rivers with ease and still have enough room to accommodate a large number of passengers. The 50–75 passenger water buses are both spacious enough to accommodate light commuter and tourist traffic and small enough to fit through many cities limited infrastructure. They act as a flexible and sensible option for operators who want to effectively meet demand without dealing with the difficulties that come with larger vessels.

By operation, Intercity segment for the Water Bus market is projected to grow at highest market share during the forecast period.

The water bus industry’s intercity segment is anticipated to have the highest market share from 2024 to 2030 based on operation because of its crucial role in delivering effective, specialized transportation in metropolitan areas. In addition to providing a pleasant and scenic substitute for conventional transportation, intercity water buses also efficiently reduce traffic jams and link important locations within cities. They are an important part of urban transit strategies because their integration into the public transportation system improves urban mobility and corresponds with the growing demand for sustainable and alternative transportation solutions.

North America holds the second highest market share in the region for the Water Bus market.

North America region holds the second-highest market share in the water bus industry specifically due to rising urbanization and demand for eco-friendly and alternative modes of transportation. Water bus services have been established in cities like New York and Seattle to reduce traffic and offer beautiful travel options. Furthermore, the expansion of water bus services is aided by North America’s emphasis on enhancing public transportation infrastructure and investigating environmentally friendly substitutes. North America is a major player in the water bus market, despite having a smaller market than Europe. This is due in part to its investment in modern transit solutions and its growth in waterfront development.

Major players in the Water Bus Market are:

  • Damen Shipyards Group (Netherlands),
  • Icarus Marine (South Africa)
  • Mavi Deniz Çevre Hiz A.S. (Turkey)
  • Incat Crowther (Australia)
  • Ares Shipyard Inc. (Turkey).

 

These companies have well-equipped, strong distribution networks across North America, Europe, Asia Pacific, the Middle East, Latin America & Africa.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/water-bus-market-264760668.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Water Bus Market worth $1.64 Billion by 2030, at a CAGR of 5.1%

Public Cloud Market Future Scope, Size, Share, Growing Demand, Opportunities, Key Segments And Forecast To 2027

“AWS (US), Microsoft (US), Google (US), Salesforce (US), Alibaba Cloud (China), Oracle (US), IBM (US), SAP (Germany), Tencent (China), Workday (US), Fujitsu (Japan), VMWare (US), Rackspace (US), HPE (US), Adobe (US), NEC (Japan), Cisco (US), Dell Technologies (US), ServiceNow (US), OVH (France), Huawei (China), Verizon (US), OrangeGroup (France), NetApp (US), dinCloud (US), Vultr (US), Megaport (Australia), AppScale (US), Zymr (US).”
Public Cloud Market by Service Model (Infrastructure as a Service, Platform as a Service, Software as a Service, Organization Size (Large enterprises, Small and Medium Enterprises (SMEs)), Vertical and Region – Global Forecast to 2027.

The public cloud market is projected to grow from USD 444.7 billion in 2022 to USD 987.7 billion by 2027, reflecting a Compound Annual Growth Rate (CAGR) of 17.3%. Public cloud services, accessible via the internet, are provided and managed by third-party cloud service providers on a pay-per-use basis. These services can be owned, managed, and operated by businesses, educational institutions, government entities, or a combination of these groups, as well as individual users.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75044022  

As per vertical, retail and consumer goods segment to grow at the highest CAGR during the forecast period

The vertical segment is further sub-segmented into BFSI, telecommunications, IT and ITeS, government and public sector, retail and consumer goods, manufacturing, energy and utilities, media and entertainment, healthcare and life sciences, and other verticals.

As per vertical, retail and consumer goods is expected to grow at the highest CAGR of 20.6% during the forecast period. The dynamics and commercial environment of the retail and consumer products sector have been significantly altered by technology in recent years. Due to technological advancements, customers may now communicate their wants and needs to retailers in a clear and concise manner. Retailers are utilizing cutting-edge technologies and techniques to enhance customer experience, boost operational effectiveness, and save costs. The need for real-time insights has accelerated the adoption of public cloud technology due to the time- and money-consuming nature of maintaining, storing, and analyzing data. The incorporation of public cloud services has significantly cut IT costs for the retail sector and improved workflow. Identifying customer preferences and behavior to offer personalized shopping experiences has become easier compared to cloud retail research and the rising popularity of social media. The public cloud benefits the retail and consumer goods industries by enabling businesses to enhance user experiences through the development of customer-centric strategies and a strong online presence. Due to their strong compute and on-demand storage capabilities, cloud-based solutions make it possible to store and manage vast amounts of both structured and unstructured data.

Small and medium-sized enterprises, by organization size, to grow at highest CAGR during forecast period

The public cloud market by organization size categorized into SMEs and large enterprises. The SMEs segment faces resource challenges in comparison to the large enterprise category. Small businesses are looking for cost-effective infrastructures that still give them the flexibility and responsiveness they need to meet their growing IT needs. In this scenario, the public cloud model performs exceptionally well in terms of great scalability and simplicity of performing critical IT activities. Due to the simplicity and adaptability of these services, hence, SMEs are quickly adopting cloud infrastructure services, and demand is anticipated to increase during the projection period. Furthermore, the pay-as-you-go approach, which gives them flexibility in how they can manage their IT infrastructure. Therefore, SMEs are implementing the public cloud to obtain a competitive edge, which would allow quick responses, timely choices, and overall increased corporate efficiency. Oracle, IBM, Google, and Adobe are some of the leading providers of public clouds to SMEs.

The public cloud market by region devided into five major regions including North America, Latin America, Europe, MEA, and APAC. High adoption of IT services and presence of major cloud providers in North America helped the region to gain majority of the market share. In 2022, North America held the largest market size in the public cloud market and the trend is expected to continue during the forecast period. However, the presence of large SMEs, and the focuse of SMEs on reducing the OPEX and CAPEX is expected to create new growth opportunities for public cloud market in the APAC region. To fullfill those increasing demand vendors present in the market have been continuously investing in APAC region. For instance, to increase its presence in APAC AWS in October 2022 announced to invest  US$5 billion (190 billion Thai Baht) in Thailand with a new infrastructure region, which will be supported by a the country over the next 15 years.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=75044022  

Unique Features in the Public Cloud Market

One of the standout features of the public cloud is its ability to scale resources on-demand. Whether a business needs more computing power, storage, or bandwidth, the public cloud can instantly provide it without requiring additional hardware or infrastructure investments. This flexibility allows organizations to dynamically adjust their usage based on current needs, ensuring optimal performance during peak times and cost-efficiency during slower periods.

The public cloud operates on a consumption-based pricing model, where users are charged only for the resources they consume. This pay-per-use structure allows businesses to avoid the capital expenditures associated with maintaining in-house infrastructure, making cloud services more cost-effective and predictable. The flexibility of this model is particularly beneficial for organizations with fluctuating workloads or seasonal demands.

Public cloud services are fully managed by third-party providers, such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud. These cloud service providers handle infrastructure maintenance, security, updates, and performance optimization, freeing organizations from the burden of managing their own data centers. This allows businesses to focus on core activities while leveraging the expertise and resources of cloud providers.

Public cloud services are accessible from anywhere with an internet connection, providing a high degree of mobility and flexibility for businesses. This feature is crucial for global enterprises, as it enables teams to collaborate and access the same cloud resources, regardless of their geographic location. Public cloud providers also offer data centers in multiple regions, allowing organizations to host their applications closer to their users, reducing latency, and improving performance.

The public cloud operates on a multi-tenancy model, where multiple users or organizations share the same physical infrastructure while keeping their data and operations isolated. This architecture enables cloud providers to maximize resource efficiency, resulting in lower costs for users. It also ensures that businesses can scale without being constrained by physical hardware limitations.

Major Highlights of the Public Cloud Market

One of the most appealing aspects of the public cloud is its pay-per-use pricing model. Businesses are only charged for the resources they actually consume, making the public cloud a highly cost-effective solution, especially for organizations with fluctuating workloads. This model reduces the need for heavy capital investments in IT infrastructure, allowing businesses to optimize their spending and scale efficiently.

Public cloud services are provided and managed by leading technology companies, such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud. These providers offer a comprehensive suite of services, including computing power, storage, networking, security, and machine learning capabilities. They also handle maintenance, security, and updates, allowing businesses to focus on their core operations while leveraging cutting-edge technologies.

Public cloud platforms are accessible from anywhere with an internet connection, making them an ideal solution for businesses operating in multiple locations. This global accessibility enables teams to collaborate in real-time, regardless of geographic boundaries, and ensures that cloud services can be accessed seamlessly across regions. The presence of multiple data centers worldwide also reduces latency and enhances user experience for globally distributed applications.

The public cloud offers unparalleled scalability, allowing businesses to instantly scale up or down based on demand. This elasticity ensures that organizations can handle varying workloads without overcommitting resources. Whether dealing with seasonal traffic spikes or ongoing growth, public cloud infrastructure provides the flexibility needed to support evolving business needs.

Despite the shared infrastructure model, public cloud platforms offer advanced security features, including data encryption, access controls, identity management, and real-time threat detection. Public cloud providers also adhere to stringent compliance standards, ensuring that businesses can meet regulatory requirements across industries. This high level of security is a significant factor contributing to the growing trust and adoption of public cloud services.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=75044022  

Top Companies in the Public Cloud Market

Some of the major public cloud market vendors are AWS (US), Microsoft (US), Google (US), Salesforce (US), Alibaba Cloud (China), Oracle (US), IBM (US), SAP (Germany), Tencent (China), Workday (US), Fujitsu (Japan), VMWare (US), Rackspace (US), HPE (US), Adobe (US), NEC (Japan), Cisco (US), Dell Technologies (US), ServiceNow (US), OVH (France), Huawei (China), Verizon (US), OrangeGroup (France), NetApp (US), dinCloud (US), Vultr (US), Megaport (Australia), AppScale (US), Zymr (US), Genesis Cloud (Germany), Ekco (Ireland), Tudip Technologies (India), ORock Technologies (US), and CloudFlex (Nigeria).

AppScale was founded in 2013 and is headquartered in Queensland, Australia. AppScale is cloud software that allows you to run AWS workloads on users servers without any code modification. AppScale operates by simulating native AWS cloud services such as EC2, S3, EBS, and others on servers that are not under AWS’s control. By enabling the exact same tools, procedures, and APIs that users would use in AWS, AppScale enables the deployment of workloads on public infrastructure. AppScale can run on nearly any infrastructure, whether it comes from a colocation service provider, operates on bare metal, or is installed on-site due to its adaptable installation and adjustable configuration. Each deployment exposes specific AWS API endpoints that can be accessed by any applications and workloads that utilize the public cloud services provided by AWS for their fundamental architecture. Different policies or regulations may be in effect because each AppScale deployment is self-contained. Further, AppScale can assist users with their goals of lowering costs, increasing control, or resolving privacy, security, or compliance challenges.

Verizon was founded in 1983 and is headquartered in New Jersey, US. Verizon provides communications, information, and entertainment products and services to consumers, businesses, and governmental agencies. The company offers products across business communications, mobility, network, security, IoT, and consumer experience services. In the public cloud market, the company offers Verizon Cloud, which is a managed computing platform that enables the provision of computing resources for mission-critical applications in minutes. Verizon Cloud lets customers control processing, storage, and memory resources, and allows them to deploy server capacity on demand. Verizon Cloud services are available in both sell and resale models. It serves various industries, such as construction, BFSI, healthcare, retail, transportation and logistics, technology, travel, and hospitality. The company has 150 locations across North America, Europe, Asia Pacific, and Latin America.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/public-cloud-market-75044022.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Public Cloud Market Future Scope, Size, Share, Growing Demand, Opportunities, Key Segments And Forecast To 2027

Gastric Cancer Pipeline Insights, Treatment Drugs, Clinical Trials and Companies 2024

DelveInsight’s, “Gastric Cancer Pipeline Insight 2024” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Explore our comprehensive Gastric Cancer Pipeline Report to stay informed about the latest advancements. Download copy now @ Gastric Cancer Pipeline Outlook

 

Key Takeaways from the Gastric Cancer Pipeline Report

  • In September 2024:- Jazz Pharmaceuticals- A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Without Tislelizumab in Subjects With HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA). This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzumab given with chemotherapy.
  • In September 2024:- Ono Pharmaceutical Co. Ltd- A Randomized, Multicenter, Open-label, Phase III Study to Compare the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab, Fluoropyrimidine-based and Platinum-based Chemotherapy (Hereinafter Referred to as “Chemotherapy”) Versus Chemotherapy in Chemotherapy-naïve Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
  • August 2024:- Bold Therapeutics, Inc.- BOLD-100 is an intravenously administered sterile solution containing the ruthenium-based small molecule. BOLD-100 has been shown to preferentially decrease the expression of GRP78 in tumour cells and ER stressed cells when compared to normal cells. BOLD-100 will be combined with cytotoxic FOLFOX chemotherapy in this study, with a dose escalation cohort to ensure tolerability and safety, followed by a cohort expansion phase.
  • August 2024:- AstraZeneca- A Phase 1b/2 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of Trastuzumab Deruxtecan (T-DXd) Monotherapy and Combinations in Adult Participants With HER2-expressing Gastric Cancer (DESTINY-Gastric-03)
  • DelveInsight’s Gastric Cancer pipeline report depicts a robust space with 180+ active players working to develop 200+ pipeline therapies for Gastric Cancer treatment.
  • The leading Gastric Cancer Companies such as Linton Pharm Co. Ltd., Shanghai Henlius Biotech, RAPT Therapeutics, AstraZeneca, Astellas Pharma, Minneamrita Therapeutics, Aston Science, Servier Bio-Innovation LLC, Bukwang Pharmaceutical, Taiho Oncology, Inc., Novartis Pharmaceuticals, Base Therapeutics (Shanghai) Co., Ltd, Shanghai Miracogen Inc., RemeGen Co., Ltd., Idience Co., Ltd., BeiGene, Ono Pharmaceutical Co. Ltd, Elevar Therapeutics, R-Pharm, Innovent Biologics (Suzhou) Co. Ltd., MacroGenics, Sichuan Baili Pharmaceutical Co., Ltd., LianBio LLC, and Janssen Pharmaceutical, and others.
  • Promising Gastric Cancer Therapies such as Avelumab, BBI608, Camrelizumab, Catumaxomab, RAPA-201, SHR-1210, Amivantamab, Atezolizumab, Bevacizumab, Cabozantinib, Cinrebafusp alfa, Crizotinib, DKN-01, DP303c, Eflornithine, EP0057, Epacadostat, FLX475, Futibatinib, GEN-001, HLX07, HLX22, Infigratinib, KH903, Lenvatinib, Masitinib, MAX-40279, MRG002, MRG003, Niraparib, Savolitinib, Minnelide, SHR-1701, Margetuximab, Bemarituzumab, Evorpacept, Lenvatinib, CDK-004, TPX-0022,  TCRx_T Cells,  IN10018, IMU-131, SOT102, CT041, AB011, Zanidatamab, NC410,  PT 886, PRS-343, Oraxol, CA-4948,  Q702,  ACE1702, SI-B001, TT-4, LUM015,  LB 1908, CUE-102,  TORL-2-307-MAB,  OBI-833/OBI-821,  ASP2138, NC410, SO-C101, HC-5404-FU, CPL304110,  LNS8801, RGX-202-01, A166, GZ17-6.02, HMPL-453,  CCT303-406, VMD-928,  ITI 4000, PAb 001, and others.

 

 Dive into our Gastric Cancer Pipeline Report to uncover promising therapies and breakthroughs. Gain insights that could shape the future of oncology @ Gastric Cancer Treatment Therapies

 

Gastric Cancer Emerging Drugs Profile

  • Catumaxomab: Linton Pharm Co. Ltd.

Catumaxomab is a bispecific monoclonal antibody that binds to EpCAM (the epithelial cell adhesion molecule) on the tumor cell–and CD3 on the T cell, recruits immune accessory cells through FcγR binding at the same time. Catumaxomab kills tumor cells by engaging T cell and accessory cell mediated cytotoxicity and has the potential to induce long-term vaccinal effects. It is co-developed by Trion Pharma and Neovii Biotech. Currently it is in Phase III stage of clinical trial evaluation to treat Gastric Cancer.

  • HLX10: Shanghai Henlius Biotech

HLX10, a novel recombinant humanized anti-programmed cell death protein 1 (PD-1) mAb independently developed by Henlius. The drug candidate works on programmed cell death-1 receptor antagonists and T lymphocyte stimulant mechanism of action. Currently being evaluated in the Phase III studies.

  • FLX475: RAPT Therapeutics

FLX475 is an oral, small molecule CCR4 antagonist designed to block the migration of regulatory T cells (Treg) specifically into tumors, but not healthy tissues, without depleting Treg throughout the body. It is in collaboration agreement with Hanmi for specific regions like Korea, Taiwan and China. Currently the drug is being evaluated in Phase II for the treatment of Gastric Cancer.

  • Savolitinib: AstraZeneca/HUTCHMED

Savolitinib is an oral, potent and highly selective MET tryokinase inhibitors (TKI). It blocks atypical activation of the MET receptor tyrosine kinase pathway that occurs because of mutations (such as exon 14 skipping alterations or other point mutations), gene amplification or protein overexpression. The drug is been developed under global licensing and collaboration agreement with AstraZeneca. The drug is in Phase II stage of clinical trials.

  • ASP 2138: Astellas Pharma

ASP-2138 is a bispecific antibody targeting CD3 and claudin 18.2 (CLDN18.2). It is administered through intravenous drip route. The drug candidate is being developed based on XmAb technology. The drug is under clinical development by Xencor and currently drug is in Phase I stage of clinical trials for the treatment of gastric cancer.

  • Minnelide : Minneamrita Therapeutics LLC

Minnelide is under clinical development by Minneamrita Therapeutics. It is administered through intravenous and oral routes. The drug candidate is a water soluble analogue of triptolide and is derived from the thunder God vine (Tripterygium wilfordii). It acts by targeting heat shock protein70 (Hsp70). Currently being investigated in a Phase I clinical trial in patients suffering with gastric cancer.

 

 Download the Gastric Cancer Pipeline Report to discover partnership opportunities and collaborate in driving impactful solutions forward @ Gastric Cancer Clinical Trials Assessment

 

Gastric Cancer Therapeutics Assessment

There are approx. 180+ key companies which are developing the therapies for Gastric Cancer. The Gastric Cancer companies which have their Gastric Cancer drug candidates in the most advanced stage, i.e. phase III include, Linton Pharm Co. Ltd.

 

DelveInsight’s Gastric Cancer pipeline report covers around 200+ products under different phases of clinical development like

  • Late stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates

 

 Dive into our detailed Gastric Cancer Pipeline Report to discover groundbreaking advancements shaping the future of cancer treatment @ Gastric Cancer Products, Companies, and Unmet Needs

 

Gastric Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Topical.

 

Gastric Cancer Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

 

Gain valuable insights into emerging therapies and innovations with our Gastric Cancer Pipeline Report @ Gastric Cancer Market Drivers and Barriers, Future Perspectives and Analyst Views

 

 Scope of the Gastric Cancer Pipeline Report

  • Coverage- Global
  • Gastric Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Gastric Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
  • Gastric Cancer Companies- Linton Pharm Co. Ltd., Shanghai Henlius Biotech, RAPT Therapeutics, AstraZeneca, Astellas Pharma, Minneamrita Therapeutics, Aston Science, Servier Bio-Innovation LLC, Bukwang Pharmaceutical, Taiho Oncology, Inc., Novartis Pharmaceuticals, Base Therapeutics (Shanghai) Co., Ltd, Shanghai Miracogen Inc., RemeGen Co., Ltd., Idience Co., Ltd., BeiGene, Ono Pharmaceutical Co. Ltd, Elevar Therapeutics, R-Pharm, Innovent Biologics (Suzhou) Co. Ltd., MacroGenics, Sichuan Baili Pharmaceutical Co., Ltd., LianBio LLC, and Janssen Pharmaceutical, and others.
  • Gastric Cancer Therapies- Avelumab, BBI608, Camrelizumab, Catumaxomab, RAPA-201, SHR-1210, Amivantamab, Atezolizumab, Bevacizumab, Cabozantinib, Cinrebafusp alfa, Crizotinib, DKN-01, DP303c, Eflornithine, EP0057, Epacadostat, FLX475, Futibatinib, GEN-001, HLX07, HLX22, Infigratinib, KH903, Lenvatinib, Masitinib, MAX-40279, MRG002, MRG003, Niraparib, Savolitinib, Minnelide, SHR-1701, Margetuximab, Bemarituzumab, Evorpacept, Lenvatinib, CDK-004, TPX-0022,  TCRx_T Cells,  IN10018, IMU-131, SOT102, CT041, AB011, Zanidatamab, NC410,  PT 886, PRS-343, Oraxol, CA-4948,  Q702,  ACE1702, SI-B001, TT-4, LUM015,  LB 1908, CUE-102,  TORL-2-307-MAB,  OBI-833/OBI-821,  ASP2138, NC410, SO-C101, HC-5404-FU, CPL304110,  LNS8801, RGX-202-01, A166, GZ17-6.02, HMPL-453,  CCT303-406, VMD-928,  ITI 4000, PAb 001, and others.

 

 Table of Content

  1. Introduction
  2. Executive Summary
  3. Gastric Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Late Stage Products (Phase III)
  7. Comparative Analysis
  8. Catumaxomab : Neovii Biotech
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. FLX475: RAPT Therapeutics
  12. Early Stage Products (Phase I)
  13. Comparative Analysis
  14. ASP 2138: Astellas Pharma
  15. Inactive Products
  16. Gastric Cancer Key Companies
  17. Gastric Cancer Key Products
  18. Gastric Cancer – Unmet Needs
  19. Gastric Cancer – Market Drivers and Barriers
  20. Gastric Cancer – Future Perspectives and Conclusion
  21. Gastric Cancer Analyst Views
  22. Gastric Cancer Key Companies
  23. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Gastric Cancer Pipeline Insights, Treatment Drugs, Clinical Trials and Companies 2024

Oligonucleotide Synthesis Market Projected to Surpass USD 26.3 Billion by 2031, Witnessing 17.4% CAGR Growth

“Oligonucleotide Synthesis Market”
Global Oligonucleotide Synthesis Market size was valued at around USD 7.3 billion in 2023 to reach a value of USD 26.3 billion by 2031, at a CAGR of 17.4% over the forecast period (2024–2031).

Global Oligonucleotide Synthesis Market size was valued at around USD 6 billion in 2022 and is expected to rise from USD 7.3 billion in 2023 to reach a value of USD 26.3 billion by 2031, at a CAGR of 17.4% over the forecast period (2024–2031).

Oligonucleotide synthesis market has been witnessing notable progress due to rising demand for customized oligonucleotides in diagnostics, research purposes, and therapeutics impacted by the growing number of improvements in genomics and personalized medicine. Moreover, modernizations in synthesis technology, comprising high throughput and automation are reducing costs and improving efficiency. The market is also driven by expanding applications in life sciences and the growing demand for synthetic biology.

Rising interest in genomics and personalized medicine is significantly impacting the need for custom-made oligonucleotides. High-throughput and automation technologies are also improving the efficiency of synthesis and its scalability. This makes these processes more cost-effective and faster. Another trend witnessed in the market is the growing emphasis on oligonucleotide-enabled treatments like RNA interference and antisense oligonucleotides, which is speedily gaining prominence. The progress and expansion of synthetic biology is offering fresh avenues for the use of oligonucleotide in molecular diagnosis and gene editing. In addition, rising focus on tailored solutions and high-quality products to cater to certain clinical and research needs is trending in the market.

 

Get a Free Sample Research Report:

https://www.skyquestt.com/sample-request/oligonucleotide-synthesis-market

 

Oligonucleotide Synthesis Market Segmental Analysis

Global Oligonucleotide Synthesis Market is segmented by Product, Application, End User, and region. 

Based on Product, the market is segmented into Oligonucleotide-based Drugs (Antisense Oligonucleotide-based drug, siRNA oligonucleotide-based drug, Other oligonucleotide-based drug), Synthesized Oligonucleotides (Primers, Probes, DNA Oligos, RNA Oligos, Other Synthesized Oligos (Customized Oligos, Predesigned Oligos), Reagents & Consumables, and Equipment. 

Based on Application, the market is segmented into Therapeutic Applications (Disease Type (Neurological Disorders, Rare Diseases, Other Diseases), Research Applications (PCR, Sequencing, Other Research Applications), and Diagnostic Applications. 

Based on End User, the market is segmented into Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, Academic Research Institutes. 

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

 

Integration with CRISPR Technology to Drive Innovations in Synthesis and Designs

A number of improvements and developments are witnessed in the oligonucleotide synthesis market, including advanced synthesis methods, customized alternatives, and integration with CRISPR-like technologies. The improvements in enzymatic methods and solid-stage synthesis are growing prominence and decreasing the rate of mistakes. Improved capabilities for customized design of oligonucleotide are useful for certain dedicated therapeutic and research requirements, enabling for more accurate applications. Moreover, the growth of (NGS) next-generation sequencing is fueling the demand for superior quality oligonucleotides for target sequencing and library preparation. This also comprises emphasis on oligonucleotides in applications like CRISPR gene-editing, thus impacting innovations in synthesis and design. To support this, companies are also capitalizing in scalable manufacturing process to satisfy the mounting demand for therapeutic oligonucleotides.

  • In May 2024, Eurofins Genomics US, launched a modernized novel solution that allows the development of oligos at an appealing price-point, mainly democratising the DNA and enhancing accessibility of oligos to all for research purposes. 
  • In December 2022, Merck signed a non-binding MoU with Synplogen, a new entrant. Both businesses will work with the objective of combining their competencies to offer simplified manufacturing, testing, and development of viral vector gene treatments for Japan.
  • In June 2022, Agilent Technologies Inc. unveiled its improved software, named ‘MassHunter BioConfirm 12.0’. It supports the data produced by Agilent high-resolution LC/MS for better purity analysis of oligonucleotide and sequence validation.
  • In October 2023, Integrated DNA Technologies (IDT), an operating Life Sciences department of Danaher Corporation pronounced the accomplishment of its novel facility for Therapeutic Oligonucleotide Manufacturing in Coralville, lowa. This entry in therapeutics space allows IDT to produce research products using cGMP gene therapy and grade cell reagents to offer research people with sole companion that helps speedy transition from laboratory to therapeutic progress.

 

Ask for Customization:

https://www.skyquestt.com/speak-with-analyst/oligonucleotide-synthesis-market

 

The report covers the following players: 

  • Danaher Corporation 
  • Thermo Fisher Scientific Inc. 
  • Merck KGaA 
  • Eurofins Scientific 
  • Agilent Technologies, Inc. 
  • Kaneka Corporation 
  • Azenta, Inc. 
  • Sarepta Therapeutics, Inc. 
  • AstraZeneca 
  • Astellas Pharma Inc. 
  • Jazz Pharmaceuticals PLC 
  • Nippon Shinyaku, Co. Ltd. (NS Pharma, Inc.) 
  • Ionis Pharmaceuticals, Inc. 
  • Novartis AG 
  • OligoMaker ApS (Part of TAG Copenhagen A/S) 
  • Biolegio BV 
  • Biolytic Lab Performance, Inc. 
  • Bio-Synthesis, Inc. 
  • Creative Biogene 
  • Reprocell, Inc.

 

View report summary and Table of Contents (TOC):

https://www.skyquestt.com/report/oligonucleotide-synthesis-market

 

This report covers the following segments:

  1. A. Product
  2. Oligonucleotide-Based Drugs (Antisense Oligonucleotide-based drug, siRNA oligonucleotide-based drug, Other oligonucleotide-based drug)
  3. Synthesized Oligonucleotides (Primers, Probes, DNA Oligos, RNA Oligos, Other Synthesized Oligos (Customized Oligos, Predesigned Oligos))
  4. Reagents & Consumables
  5. Equipment 
  1. B. Application
  2. Therapeutic Applications [Disease Type (Neurological Disorders, Rare Diseases, Other Diseases)]
  3. Research Applications (PCR, Sequencing, Other Research Applications)
  4. Diagnostic Applications
  1. C. End User
  2. Hospitals
  3. Pharmaceutical & Biotechnology Companies
  4. Diagnostic Laboratories
  5. CROs and CMOs
  6. Academic Research Institutes

 

Escalating Demand for Personalized Medicine and Expanding Applications to Further Propel Market

In summary, the market for oligonucleotide synthesis presents an evolving and dynamic ecology combining medicine, technology, and science. As research is engaged in unlocking complete potential of nucleic acid-enabled therapies and tools, the need for quality and customized oligonucleotides will further increase. This impact innovation and fuels the industry towards more personalized healthcare and precision medicine.

 

Visit Our Website: https://www.skyquestt.com/

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/oligonucleotide-synthesis-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Oligonucleotide Synthesis Market Projected to Surpass USD 26.3 Billion by 2031, Witnessing 17.4% CAGR Growth

Timing Devices Market worth $7.59 Billion by 2030, at a CAGR of 6.4%

“Timing Devices Market”
The global Timing Devices Market in terms of revenue is estimated to be worth $5.24 billion in 2024 and is poised to reach $7.59 billion by 2030, growing at a CAGR of 6.4% during the forecast period.

The report “Timing Devices Market by Oscillators- MEMS (SPMO, TCMO, VCMO, FSMO, DCMO, SSMO), Crystal (SPXO, TCXO, VCXO, FCXO, OCXO, SSXO, HiFlex, MCXO), Ceramic; Atomic Clocks; Clock Generators; Clock Buffers; and Jitter Attenuators – Global Forecast to 2030” The timing devices Industry is projected to grow from USD 5.24 billion in 2024 and is expected to reach USD 7.59 billion by 2030, growing at a CAGR of 6.4%  from 2024 to 2030.

The telecommunication industry drives the timing devices Industry. Wireless networks need precise timing and synchronization as well as faster data transfer while the development of 5G technology takes place. This also applies for satellite communication systems, broadcast services and other spatial applications. In future whether in 5G or 6G there will be an enormous amount of data crossing through with extremely low latency therefore requiring accurate synchronization between the network components and their devices. In this regard timing becomes very important because there will be different network elements that must be coordinated appropriately at all times. Timing devices help synchronize various networks nodes such that there is uninterrupted communication between them while reducing interference at the same time. Also, for any successful coordination and efficient processing of data on these edge devices requires precise timekeeping.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121133929

Browse 220 market data Tables and 68 Figures spread throug 228 Pages and in-depth TOC on “Timing Devices Market”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/timing-device-market-121133929.html

Timing Devices Market

Atomic clocks Industryis expected to witness highest CAGR during the forecast period.

The Industry for atomic clocks is growing due to the unique precision and accuracy, necessary for satellite navigation systems, scientific research and telecommunications. As the satellite-based navigation systems including GPS expands their operations, atomic clocks play a crucial role in synchronizing satellites constellations thus providing reliable positions. Their miniaturization along with advancements like optical lattice clocks are responsible for a surge in their usage across various industries. Apart from being used for precise timekeeping in industries such as finance, military and aerospace these devices are needed in supporting infrastructure such as power grids and transport networks etc. Furthermore, increasing demand for quantum technologies drives the need for atomic clocks.

The crystal segment in the timing devices Industry is expected to capture largest share during the forecast period.

The crystal segment occupied the top position in the market in 2024 owing to the extensive usage of quartz crystals in electronic devices for accurate timing and frequency regulation. Quartz crystals are cost-efficient, dependable, and consistent which makes them a preferred choice in different applications extending from consumer electronics to industrial machines. Their leadership is supported by their maturity of technology plus already established supply chain while their flexibility meets various frequency and stability demands. Besides growth of consumer electronics Industry , other factors contributing to increasing demand for crystal materials include technological innovations made on miniaturization, precision improvement among other areas pertinent to crystal technology.

Asia Pacific is expected to hold the largest share of the timing devices Industry during the forecast period.

Asia Pacific dominates in the timing devices Industry driven by the increasing demand for electronic items such as consumer electronics, automotive electronics, and wearable electronics in this region is responsible for the expansion. The rising demand for various timing ICs used in electronics and automotive applications, increasing number of mobile phone utilization, broadcast transmitters, and consumers high disposable payments in the region are some of the determinants of market expansion within this region.

Key Timing Devices Industry Players :

Leading players in the timing devices Industry include NIHON DEMPA KOGYO CO., LTD., (Japan), Seiko Epson Corporation (Japan), KYOCERA Corporation (Japan), TXC Corporation (Taiwan), Rakon Limited (New Zealand), and Infineon Technologies AG (Germany). Renesas Electronics Corporation (Japan), Microchip Technology Inc. (US), Texas Instruments Incorporated (US), Abracon (US), IQD Frequency Products Ltd. (UK), Vishay Intertechnology, Inc. (US), STMicroelectronics (Switzerland), SiTime Corp. (US), MtronPTI (US), CTS Corporation (US), Diodes Incorporated (US), ON Semiconductor Corporation (US), Crystek Corporation (US), Frequency Electronics, Inc. (US), Greenray Industries, Inc. (US), Oscilloquartz (Switzerland), AccuBeat Ltd. (Israel), Connor-Winfield Corporation (US), and Mercury Inc. (Taiwan) are few other key companies operating in the timing devices Industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/timing-device-market-121133929.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Timing Devices Market worth $7.59 Billion by 2030, at a CAGR of 6.4%